p53 and MDM-2 expression in myelodysplastic syndrome (MDS) following autologous bone marrow transplantation (auto-BMT) for lymphoma

被引：0
|
作者：
Brynes, RK
Wilson, CS
Kim, AB
McCourty, A
机构：
[1] CITY HOPE NATL MED CTR,DUARTE,CA 91010
[2] UNIV ARKANSAS,LITTLE ROCK,AR 72204
来源：
LABORATORY INVESTIGATION | 1997年 / 76卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：703 / 703
页数：1
相关论文
共 50 条
  • [1] Myelodysplasic syndrome (MDS) after autologous bone marrow transplantation (auto-BMT) for lymphoma: Morphologic features
    Wilson, CS
    Traweek, ST
    Slovak, ML
    Niland, JC
    Brynes, RK
    LABORATORY INVESTIGATION, 1996, 74 (01) : 735 - 735
  • [2] Expression of p53, MDM2, p21(waf1), bcl-2, and retinoblastoma gene proteins in myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma
    Brynes, RK
    Wilson, CS
    Kim, AB
    McCourty, A
    MODERN PATHOLOGY, 1997, 10 (11) : 1120 - 1127
  • [3] Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS
    DeWitte, T
    VanBiezen, A
    Hermans, J
    Labopin, M
    Runde, V
    Or, R
    Meloni, G
    Mauri, SB
    Carella, A
    Apperley, J
    Gratwohl, A
    Laporte, JP
    BLOOD, 1997, 90 (10) : 3853 - 3857
  • [4] Analysis of p53 and mdm-2 expression in 18 patients with Sezary syndrome
    Marks, DI
    Vonderheid, EC
    Kurz, BW
    Bigler, RD
    Sinha, K
    Morgan, DA
    Sukman, A
    Nowell, PC
    Haines, DS
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) : 890 - 899
  • [5] P53 AND PUMA EXPRESSIONS IN BONE MARROW BIOPSIES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)
    Bektas, O.
    Uner, A.
    Buyukasik, Y.
    Uz, B.
    Eliacik, E.
    Isik, A.
    Haznedaroglu, I.
    Goker, H.
    Demiroglu, H.
    Aksu, S.
    Ozcebe, O.
    Sayinalp, N.
    HAEMATOLOGICA, 2012, 97 : 369 - 369
  • [6] p53 and MDM-2 gene expression in human skin
    Dazard, JE
    Augias, D
    Neel, H
    Piette, J
    Guilhou, JJ
    BassetSeguin, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (05) : C41 - C41
  • [7] Allogeneic bone marrow transplantation (BMT) in children with de novo myelodysplastic syndrome (MDS).
    Frangoul, HA
    Gooley, TA
    Sanders, JE
    BLOOD, 1998, 92 (10) : 687A - 687A
  • [8] Prognostic factors and expression of p53 and mdm-2 in uterine sarcomas
    Kim, S. H.
    Kim, J. W.
    Kim, Y. T.
    Kim, J. H.
    Yoon, B. S.
    Ryu, H. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 95 (03) : 272 - 277
  • [9] RESULTS OF THE LATIN-AMERICAN REGISTRY OF BONE MARROW TRANSPLANTATION (BMT) IN MYELODYSPLASTIC SYNDROME (MDS)
    Duarte, F.
    Santos, T. E. J.
    Funke, V. A. M.
    Colturato, V. A. R. C.
    Hamerschlak, N.
    Vilela, N. C. V.
    Lopes, L. F.
    Macedo, M. C. M. A.
    Vigorito, A. C.
    Soares, R. D. D. A.
    Paz, A.
    Stevenazzi, M.
    Diaz, L.
    Neto, A. E. H. N.
    Bettarello, G.
    Gusmao, B. M.
    Salvino, M. A.
    Calixto, R. F.
    Velloso, E. D. R. P.
    Lemes, R. P. G.
    LEUKEMIA RESEARCH, 2017, 55 : S45 - S46
  • [10] P53 Immunohistochemical Expression Is Specific for MDS and MDS/MPN in Bone Marrow
    Babu, Daniel
    Czuchlewski, David
    Arber, Daniel
    George, Tracy
    MODERN PATHOLOGY, 2015, 28 : 337A - 337A
12345